IP Library Granted Patent US 10,273,203
Granted Patent B2
US 10,273,203 · App. 15/945,542 · Granted Apr 30, 2019

Deuterated 3-methanesulfonylpropionitrile

Inventors: Gerald S. Jones (Norwood, MA); Scott A. Goodrich (Stoughton, MA); Joseph P. St. Laurent (Lakeville, MA)
Assignee: Olatec Therapeutics LLC
C07C317/28C07C315/02C07C315/04C07B2200/05C07B2200/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,273,203
App. No.
15/945,542
Granted
Apr 30, 2019
Kind
B2
Abstract

The present invention relates to purified compounds of 3-methanesulfonylpropionitrile, in which at least one of the hydrogen, oxygen, sulfur, and nitrogen atoms is substituted with a respective isotope that includes, but not limited to 2 H (deuterium), 3 H (tritium), 13 C, 14 C, 15 N, 17 O, 18 O, and 35 S. The purified compound has at least 90% purity. Preferred compounds are deuterated 3-methanesulfonylpropionitriles.

Claims (24)

1. A compound of 3-methanesulfonylpropionitrile or a pharmaceutically acceptable solvate thereof, in which at least one of the hydrogens is substituted with 2 H (deuterium).

2. The compound according to claim 1 , which is

wherein D represents deuterium.

3. The compound according to claim 2 , which is

4. The compound according to claim 2 , which is

5. The compound according to claim 2 , which is

6. A method for preparing the compound of claim 3 , comprising:

reacting 3-bromopropionitrile with an aqueous solution comprising sodium hydrosulfide (NaSH) to form a thiol,

alkylating the thiol with trideuterated-iodomethane under a basic condition to form a sulfide, and

oxidizing the sulfide with hydrogen peroxide to form the compound of claim 3 .

7. A method for preparing the compound of claim 4 , comprising:

protecting 2-bromoethanol-1,1,2,2-d 4 with a protecting group,

alkylating sodium methylsulfinate with the protected 2-bromoethanol-1,1,2,2-d 4 to form a sulfone,

removing the protected group in the sulfone by an acidic condition,

converting the de-protected sulfone to a tosylate, and

reacting the tosylate with a cyanide ion to produce the compound of claim 4 .

8. A method for preparing the compound of claim 5 , comprising:

protecting 2-bromoethanol-1,1,2,2-d 4 with a protecting group,

reacting the protected 2-bromoethanol-1,1,2,2-d 4 with an aqueous solution comprising sodium hydrosulfide (NaSH) to form a thiol,

alkylating the thiol with trideuterated-iodomethane under a basic condition to form a sulfide,

oxidizing the sulfide with hydrogen peroxide to form a sulfone,

removing the protected group in the sulfone by an acidic condition,

converting the de-protected sulfone to a tosylate, and

reacting the tosylate with a cyanide ion to produce the compound of claim 5 .

Assignments (1)
CHANGE OF NAME Recorded Nov 7, 2023
From: OLATEC THERAPEUTICS LLC
To: OLATEC THERAPEUTICS, INC.
Reel/Frame 065489/0809 →
Continuity (2)
Provisional Application 62484177 · Apr 11, 2017
Related Publication 20180290971A1 · Oct 11, 2018